Pharma and Biotech
By Sharecast
Date: Tuesday 10 Mar 2026
By Sharecast
Date: Monday 22 Dec 2025
By Michele Maatouk
Date: Monday 16 Dec 2024
(Sharecast News) - Biotech firm Graft Polymer said on Monday that it has agreed to buy Awakn Life Sciences Corp, a clinical-stage biotechnology company developing therapeutics for substance use and mental health disorders, for £4.98m.
No recent information was found.
| Currency | UK Pounds |
| Share Price | 0.15p |
| Change Today | 0.004p |
| % Change | 2.67 % |
| 52 Week High | 0.39 |
| 52 Week Low | 0.12 |
| Volume | 0 |
| Shares Issued | 6,806m |
| Market Cap | £10.48m |
| Beta | 0.02 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| CEO | Anthony Tennyson |
| Chair | Dennis Purcell |
You are here: research